Dr. Paweł Mituła is the Chief Technology Officer and Co-Founder of Healthcann. Trained as a biotechnologist and chemist, he earned his PhD in Biotechnology from the University of Life Sciences in Wrocław.

Before his tenure at Healthcann, Paweł served in significant roles at Synthos and PCC Rokita, notable entities in the chemical industry. During his time at Synthos, he was responsible for the development of liposomal technology, a critical component in the drug delivery sector. His roles varied from Research & Development Specialist to Project Coordinator, thereby acquiring a comprehensive understanding of the sector. He played a key role in the creation of new product portfolios and ensured a successful transition from laboratory-scale to high-volume commercial production.

Paweł also coordinated advanced biotechnological projects at companies such as Skotan and PureBiologics. Here, he led the development of innovative bacteriophage encapsulation systems, designed to combat the ever-growing issue of multidrug-resistant bacteria.

Besides Healthcann, Mituła and our CEO Grzegorz co-founded Sovigo, a firm focused on creating precise drug delivery systems to improve care for patients, particularly those with gastrointestinal diseases.

As the CTO at Healthcann, Paweł spearheads the company's technological vision and oversees project portfolio management. His expertise in chemical synthesis, process scaling, and process engineering is pivotal in transforming Healthcann's innovative ideas into market-ready solutions.